Pet-yksikkö

Julkaisut 2010
Publications 2010

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alakurtti K et al. Reproducibility of striatal and thalamic dopamine D2 receptor binding using (11C)raclopride with high-resolution positron emission tomography.
2 Autio A et al. PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
3 Bengel FM et al. Cardiac neurotransmission imaging: Positron emission tomography .
4 Bojsen-Møller J et al. Muscle use during double poling evaluated by positron emission tomography.
5 Bojsen-Møller J et al. Intermuscular force transmission between human plantarflexor muscles in vivo.
6 Bry M et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation .
7 Bucci M et al. Intrapericardial, but not extrapericardial, fat is an independent predictor of impaired hyperemic coronary perfusion in coronary artery disease.
8 Carlsson M, Knuuti J. Myocardial perfusion SPECT and PET.
9 Ekblad M et al. Maternal smoking during pregnancy and regional brain volumes in preterm infants.
10 Erkinjuntti T et al., toim. Muistisairaudet.
11 Fagerholm V et al. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas.
12 Fukumoto N et al. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis.
13 Grönholm-Nyman P et al. Learning and forgetting new names and objects in MCI and AD.
14 Haataja L et al. Five-year follow-up of prematurely born children with postnatally developing caudothalamic cysts.
15 Hakala M et al. Onset of neuropsychiatric symptoms after psychological trauma may result in erroneous diagnostic bias.
16 Haltia LT et al. Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects.
17 Hannukainen JC et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins discordant physical activity .
18 Hannukainen JC et al. Higher free fatty acid uptake in visceral than in abdominal subcutaneous fat tissue in men.
19 Heinonen I. The Regulation of Skeletal and Cardiac Muscle Blood Flow in Humans.
20 Heinonen I et al. Comparison of exogenous adenosine and voluntary exercise on human skeletal muscle perfusion and perfusion heterogeneity .
21 Heinonen IH et al. Regulation of human skeletal muscle perfusion and its heterogeneity during exercise in moderate hypoxia.
22 Hirvonen J, Hietala J. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.
23 Hirvonen J et al. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with (11C)raclopride PET.
24 Hirvonen J et al. Human biodistribution and radiation dosimetry of (11)C-(R)-PK11195, the prototypic PET ligand to image inflammation.
25 Hirvonen MM et al. COMT Val158Met genotype doe not alter cortical or striatal dopaminen D2 receptor availability in vivo.
26 Iozzo P et al. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals .
27 Jambor I et al. Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy.
28 Jokinen P et al. [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
29 Järvelä JT et al. Kainic acid-induced neurodegeneration and activation of inflammatory processes in organotypic hippocampal slice cultures: Treatment with cyclooxygenase-2 inhibitor does not prevent neuronal death.
30 Kajander S. CT and PET/CT Hybrid Imaging of Coronary Artery Disease.
31 Kajander S et al. Anatomy and function: PET-CT .
32 Kajander S et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease.
33 Kankaanranta L et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
34 Karlsson H et al. Research letter: Psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder.
35 Karmi A et al. Increased brain fatty acid uptake in metabolic syndrome .
36 Karvonen MK et al. Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient.
37 Kaufmann PA, Knuuti J. Ionizing radiation risks of cardiac imaging: estimates of the immeasurable.
38 Kauhanen S et al. Clinical PET imaging of insulinoma and beta-cell hyperplasia.
39 Kemppainen J et al. Autodiab-tutkimus helpottaa diabeetikon ajokyvyn objektiivista arviontia.
40 Kemppainen J et al. Reversible brain hypometabolism associated with central nervous system systemic lupus erythematosus.
41 Kiviniemi TO et al. Decreased endothelin-1 levels after acute consumption of red wine and de-alcoholized red wine.
42 Knuuti J , Saraste A . New clinical perspectives from imaging technologies for diagnosis and management of coronary artery disease.
43 Knuuti J , Tuunanen H . Metabolic imaging in myocardial ischemia and heart failure .
44 Knuuti J, Di Carli M. Imaging of Viability using PET.
45 Knuuti J, Kaufmann PA. Hybrid Imaging: PET-CT and SPECT-CT.
46 Koivuviita N et al. The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function .
47 Kokki T et al. Dual gated PET/CT imaging of small targets of the heart: Methods description and testing with a dynamic heart phantom.
48 Koskenvuo JW et al. Cardiopulmonary involvement in Fabry´s disease.
49 Koskivirta I et al. Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.
50 Kotilahti K et al. Hemodynamic responses to speech and music in newborn infants.
51 Kronström K et al. Personality traits and recovery from major depression.
52 Kudomi N et al. Extraction of input function from rat [18F]FDG PET images .
53 Laaksonen MS et al. Perfusion heterogeneity does not explain excess muscle oxygen uptake during variable intensity exercise.
54 Laitinen IEK et al. Uptake of 11C-choline in mouse atherosclerotic plaques.
55 Lee MS et al. The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease.
56 Leppänen M et al. Abnormal antenatal Doppler velocimetry and cognitive outcome in very low-birth-weight infants at 2 years of age.
57 Lind A et al. Relations between brain volumes, neuropsychological assessment and parental questionnaire in prematurely born children.
58 Lind A et al. Cognitive and neuropsychological outcomes at 5 years of age in preterm children born in the 2000s.
59 Lindholm P et al. PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
60 Lumme V et al. Cortical dopamine D2/D3 receptors and verbal memory in man.
61 Luoto P et al. Human dosimetry of carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide extrapolated from whole-body distribution kinetics and radiometabolism in rats.
62 Lyoo CH et al. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
63 Magadán-Méndez M et al. ICA based automatic segmentation of dynamic H(2)(15)O cardiac PET images.
64 Malmberg M et al. Cardiomyocyte apoptosis after cardioplegic ischemia: Comparison to unprotected regional ischemia-reperfusion.
65 Marjamäki P et al. Comparison of 2beta-carbomethoxy-3beta-(4-[18F]fluorophenyl)tropane and N-(3-[18F]fluoropropyl)-2beta-carbomethoxy-3beta-(4-fluorophenyl)nortropane, tracers for imaging dopamine transporter in rat.
66 Maron E et al. Gender differences in brain serotonin transporter availability in panic disorder.
67 Maunu J et al. Ventricular dilatation in relation to outcome at 2 years of age in very preterm infants: a prospective Finnish cohort study.
68 Miettinen J et al. Effects of intracoronary infusion of bone marrow-derived stem cells on pulmonary artery pressure and diastolic function after myocardial infarction .
69 Miettinen JA et al. Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infraction .
70 Miettinen JA et al. Determinants of functional recovery after myocardial infarction of patients treated bone marrow-derived stem cells after thrombolytic therapy .
71 Minn H et al. Impact of PET/CT on planning of radiotherapy in head and neck cancer.
72 Minn H, Vihinen P. Melanoma imaging with highly specific PET probes: ready for prime time?
73 Mosconi L et al. Increased fibrillar amyloid-B burden in normal individuals with a family history of late-onset Alzheimer's.
74 Munck P et al. Cognitive outcome at 2 years of age in Finnish infants with very low birth weight born between 2001 and 2006.
75 Nekolla S, Saraste A. PET and MRI in Cardiac Imaging.
76 Nihoyannopoulos P et al. Arrythmogenic Right ventricular Cardiomyopathy/Dysplasia.
77 Noponen T et al. Effects of improper source coupling in frequency-domain near-infrared spectroscopy.
78 Nordberg A et al. The use of PET in Alzheimer disease.
79 Nucifora G et al. Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation.
80 Näsi T et al. Correlation of visual-evoked hemodynamic responses and potentials in human brain.
81 Någren K et al. Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease.
82 Perrone-Filardi P et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: . a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology.
83 Quarta C et al. CB1 signaling in forebrain and sympathetic neurons is a key determinat of endocannabinoid actions on energy balance.
84 Rekola J et al. Effects of heat treatment of wood on hydroxylapatite type mineral precipitation and biomechanical properties in vitro.
85 Rinne J. Lewyn kappale -tauti.
86 Rinne J. Parkinsonin tauti ja muut ekstrapyramidaalisairaudet.
87 Rinne J, Remes A. Otsa-ohimolohkorappeumat.
88 Rinne JO et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.
89 Rinne JO, Någren K. Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease.
90 Rissanen E et al. Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
91 Saraste A et al. Integrated anatomy and viability assessment PET-CT.
92 Saraste A et al. Congestive heart failure .
93 Scheinin N. Early Detection of Alzheimer's Disease B-Amyloid Pathology.
94 Schrey A et al. Perfusion in free breast reconstruction flap zones assessed with positron emission tomography.
95 Schrey A et al. The limitations of tissue-oxygen measurement and positron emission tomography as additional methods for postoperative breast reconstruction free-flap monitoring.
96 Seppälä J et al. A method to improve target dose homogeneity of craniospinal irradiation using dynamic split field IMRT.
97 Siirala W et al. Predictive equations over-estimate the resting energy expenditure in amyotrophic lateral sclerosis patients who are dependent on invasive ventilation support.
98 Silvola J et al. Preliminary evaluation of novel 68Ga-DOTAVAP-PEG-P2 peptide targeting vascular adhesion protein-1.
99 Soilu-Hänninen M et al. Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's disease.
100 Stein A et al. Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction.
101 Suotunen T et al. Visual assessment of (11C)PIB PET in patients with cognitive impairment.
102 Sutinen J et al. Skeletal muscle mitochondrial DNA content and aerobic metabolism in patients with antiretroviral therapy-associated lipoatrophy.
103 Teare H et al. Radiosynthesis and evaluation of (18F)selectfluor bis(triflate).
104 Teräs M et al. Dual-gated cardiac PET - Clinical feasibility study.
105 Tolvanen T et al. Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data .
106 Tuomela J et al. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.
107 Ujula T. Studies on 68Ga-Based Agents for PET Imaging of Cancer and Inlammation.
108 Ujula T et al. Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
109 Ujula T et al. 68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats-comparison with FDG.
110 Vanninen R et al. Aivojen kuvantaminen.
111 Virta JJ et al. Midlife alcohol consumption and later risk of cognitive impairment: a twin follow-up study.
112 Virtanen KA, Nuutila P. Functional imaging of brown adipose tissue.
113 Wijns W et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
114 Zamorano JL et al., ed. The ESC Textbook of Cardiovascular Imaging.
115 Zhao L et al. Automatic cerebral and cerebellar hemisphere segmentation in 3D MRI: adaptive disconnection algorithm.
Julkaisutietokanta 24.8.2011 Publications Data Base 24.8.2011